Gilbert Halley E 4
4 · Arcutis Biotherapeutics, Inc. · Filed Nov 21, 2025
Insider Transaction Report
Form 4
Gilbert Halley E
Director
Transactions
- Sale
Common Stock
2025-11-20$27.55/sh−16,532$455,442→ 22,123 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-20−12,220→ 0 totalExercise: $7.51Exp: 2033-05-31→ Common Stock (12,220 underlying) - Exercise/Conversion
Common Stock
2025-11-20$7.51/sh+12,220$91,772→ 38,655 total
Footnotes (2)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $27.32 to $27.72, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.